Inflammatory cytokines and metabolic risk factors during growth and maturation: Influence of physical activity

Medicine and Sport Science

Volumn 55, Issue , 2010, Pages 43-55

  Rubin, Daniela A ^a   Hackney, Anthony C ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INSULIN; INTERLEUKIN 6; LIPID; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; BLOOD PRESSURE; EXERCISE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; METABOLISM; MOTOR ACTIVITY; OBESITY; PHYSIOLOGY; RISK FACTOR; SEDENTARY LIFESTYLE; SYSTOLE;

ADIPONECTIN; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; EXERCISE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LIPID METABOLISM; LIPIDS; METABOLIC SYNDROME X; MOTOR ACTIVITY; OBESITY; RESISTIN; RISK FACTORS; SEDENTARY LIFESTYLE; SYSTOLE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84926104084     PISSN: 02545020     EISSN: 16622812     Source Type: Book Series    
DOI: 10.1159/000321971     Document Type: Article

References (49)

1. Yamauchi T, Kamon J, Minokoshi Y, et al: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-1295.
2. Steppan CM, Bailey ST, Bhat S, et al: The hormone resistin links obesity to diabetes. Nature 2001;409: 307-312.
3. Fernandez-Real JM, Ricart W: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003;24:278-301.
4. Pedersen BK, Akerstrom TC, Nielsen AR, Fischer CP: Role of myokines in exercise and metabolism. J Appl Physiol 2007;103:1093-1098.
5. Pedersen BK, Febbraio MA: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 2007;102:814-826.
6. Petersen AM, Pedersen BK: The anti-inflammatory effect of exercise. J Appl Physiol 2005;98:1154-1162.
7. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003;111:1805-1812.
8. Ford ES: C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2003;108: 1053-1058.
9. Bjorge T, Engeland A, Tverdal A, Smith GD: Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. Am J Epidemiol 2008;168:30-37.
10. Stokes J 3rd, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA: Blood pressure as a risk factor for cardiovascular disease: the Framingham Study - 30 years of follow-up. Hypertension 1989;13:I13-I18.
11. Wilson PW, Abbott RD, Castelli WP: High density lipoprotein cholesterol and mortality: the Framingham Heart Study. Arteriosclerosis 1988;8: 737-741.
12. Williams DE, Cadwell BL, Cheng YJ, et al: Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics 2005;116:1122-1236.
13. Lee S, Bacha F, Gungor N, Arslanian SA: Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr 2006; 148:188-194.
14. Williams DP, Going SB, Lohman TG, et al: Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health 1992;82:358-363.
15. McGill HC Jr, McMahan CA, Herderick EE, Malcom GT, Tracy RE, Strong JP: Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 2000;72: 1307S-1315S.
16. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
17. Morrison JA, Friedman LA, Wang P, Glueck CJ: Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 2008;152:201-206.
18. Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT: Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med 2009;163:371-377.
19. Ekelund U, Anderssen S, Andersen LB, et al: Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth. Am J Clin Nutr 2009;89:90-96.
20. Bacha F, Saad R, Gungor N, Arslanian SA: Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004;27:547-552.
21. Asayama K, Hayashibe H, Dobashi K, et al: Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res 2003; 11:1072-1079.
22. Rubin DA, McMurray RG, Harrell JS, Hackney AC, Haqq AM: Do surrogate markers for adiposity relate to cytokines in adolescents? J Invest Med 2008;56: 786-792.
23. Weiss R, Dziura J, Burgert TS, et al: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-2374.
24. Gallistl S, Sudi KM, Cvirn G, Muntean W, Borkenstein M: Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord 2001;25:529-532.
25. Moon YS, Kim DH, Song DK: Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metabolism 2004;53:863-867.
26. Chu NF, Shen MH, Wu DM, Lai CJ: Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children. Obes Res 2005; 13:2014-2020.
27. Gerber M, Boettner A, Seidel B, et al: Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab 2005;90:4503-4509.
28. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S: Resistin, central obesity, and type 2 diabetes. Lancet 2002;359:46-57.
29. Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K: Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents. Metabolism 2004;53:1336-1341.
30. de Ferranti S, Mozaffarian D: The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008;54:945-955.
31. Rubin DA, McMurray RG, Harrell JS, Hackney AC, Thorpe DE, Haqq AM: The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise. Metabolism 2008; 57:683-690.
32. Huang KC, Lue BH, Yen RF, et al: Plasma adiponectin levels and metabolic factors in nondiabetic adolescents. Obes Res 2004;12:119-124.
33. Cianflone K, Lu H, Smith J, Yu W, Wang H: Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children. Clin Endocrinol (Oxf) 2005;62:567-572.
34. Ouchi N, Kihara S, Arita Y, et al: Novel modulator for endothelial adhesion molecules: adipocytederived plasma protein adiponectin. Circulation 1999;100:2473-2476.
35. Kubota N, Terauchi Y, Yamauchi T, et al: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002;277:25863-25866.
36. Huang KC, Chen CL, Chuang LM, Ho SR, Tai TY, Yang WS: Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab 2003;88:4130-4134.
37. Gilardini L, Parati G, Sartorio A, Mazzilli G, Pontiggia B, Invitti C: Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens 2008;22:75-82.
38. Jarvisalo MJ, Harmoinen A, Hakanen M, et al: Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002;22:1323-1328.
39. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Lulka D, Walczak M: Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. Neuro Endocrinol Lett 2005;26:242-246.
40. Ischander M, Zaldivar F Jr, Eliakim A, et al: Physical activity, growth, and inflammatory mediators in BMI-matched female adolescents. Med Sci Sports Exerc 2007;39:1131-1138.
41. Rubin DA, McMurray RG, Harrell JS, Thorpe DE, Hackney AC: Vigorous physical activity and cytokines in adolescents. Eur J Appl Physiol 2008;103:495-500.
42. Platat C, Wagner A, Klumpp T, Schweitzer B, Simon C: Relationships of physical activity with metabolic syndrome features and low-grade inflammation in adolescents. Diabetologia 2006;49:2078-2085.
43. Balagopal P, George D, Yarandi H, Funanage V, Bayne E: Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. J Clin Endocrinol Metab 2005;90:6192-6197.
44. Kim ES, Im JA, Kim KC, et al: Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth. Obesity (Silver Spring) 2007;15:3023-3030.
45. Rosenbaum M, Nonas C, Weil R, et al: School-based intervention acutely improves insulin sensitivity and decreases inflammatory markers and body fatness in junior high school students. J Clin Endocrinol Metab 2007;92:504-508.
46. Kelly AS, Steinberger J, Olson TP, Dengel DR: In the absence of weight loss, exercise training does not improve adipokines or oxidative stress in overweight children. Metabolism 2007;56:1005-1009.
47. Froberg K, Andersen LB: Mini review: physical activity and fitness and its relations to cardiovascular disease risk factors in children. Int J Obes 2005; 29(suppl 2):S34-S39.
48. Strong WB, Malina RM, Blimkie CJ, et al: Evidence based physical activity for school-age youth. J Pediatr 2005;146:732-737.
49. Chan DC, Barrett PH, Watts GF: Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders. Curr Opin Lipidol 2006;17:28-36.